首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Vitamin D–Dependent Rickets Type 1B (25‐Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?
【24h】

Vitamin D–Dependent Rickets Type 1B (25‐Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?

机译:维生素D依赖性佝偻病型1B型(25-羟化酶缺乏):罕见的病症或误诊病症?

获取原文
获取原文并翻译 | 示例
           

摘要

ABSTRACT Vitamin D requires a two‐step activation by hydroxylation: The first step is catalyzed by hepatic 25‐hydroxylase ( CYP2R1 , 11p15.2) and the second one is catalyzed by renal 1α‐hydroxylase ( CYP27B1 , 12q13.1), which produces the active hormonal form of 1,25‐(OH) 2 D. Mutations of CYP2R1 have been associated with vitamin D–dependent rickets type 1B (VDDR1B), a very rare condition that has only been reported to affect 4 families to date. We describe 7 patients from 2 unrelated families who presented with homozygous loss‐of‐function mutations of CYP2R1 . Heterozygous mutations were present in their normal parents. We identified a new c.124_138delinsCGG (p.Gly42_Leu46delinsArg) variation and the previously published c.296TC (p.Leu99Pro) mutation. Functional in vitro studies confirmed loss‐of‐function enzymatic activity in both cases. We discuss the difficulties in establishing the correct diagnosis and the specific biochemical pattern, namely, very low 25‐OH‐D suggestive of classical vitamin D deficiency, in the face of normal/high concentrations of 1,25‐(OH) 2 D. Siblings exhibited the three stages of rickets based on biochemical and radiographic findings. Interestingly, adult patients were able to maintain normal mineral metabolism without vitamin D supplementation. One index case presented with a partial improvement with 1alfa‐hydroxyvitamin D 3 or alfacalcidol (1α‐OH‐D 3 ) treatment, and we observed a dramatic increase in the 1,25‐(OH) 2 D serum concentration, which indicated the role of accessory 25‐hydroxylase enzymes. Lastly, in patients who received calcifediol (25‐OH‐D 3 ), we documented normal 24‐hydroxylase activity ( CYP24A1 ). For the first time, and according to the concept of personalized medicine, we demonstrate dramatic improvements in patients who were given 25‐OH‐D therapy (clinical symptoms, biochemical data, and bone densitometry). In conclusion, the current study further expands the CYP2R1 mutation spectrum. We note that VDDR1B could be easily mistaken for classical vitamin D deficiency. ? 2017 American Society for Bone and Mineral Research.
机译:摘要维生素D需要通过羟化的两步活化:通过肝25-羟化物(CYP2R1,11p15.2)催化第一步,第二步骤通过肾1α-羟化物(CYP27B1,12Q13.1)催化,产生CYP2R1的1,25-(OH)2 D的活性激素形式与维生素D依赖性佝偻病型1B(VDDR1B)有关,只有据报道迄今为止仅涉及4个家庭的非常罕见的病症。我们描述了来自2名不相关的家族患者,他们呈现了CYP2R1的纯合功能突变。杂合突变在其正常的父母中存在。我们确定了一个新的C.124_138Delinscgg(p.gly42_leu46delinsarg)变异,先前公布的C.296T> C(P.Leu99Pro)突变。功能性在体外研究证实了两种情况下的功能性酶活性。我们讨论建立正确诊断和特定生化模式的困难,即非常低的25-OH-D暗示古典维生素D缺乏症,面对25-(OH)2 D的正常/高浓度。兄弟姐妹基于生化和放射线摄影结果表明了佝偻病的三个阶段。有趣的是,成年患者能够在没有维生素D补充的情况下保持正常的矿物代谢。具有1ALFA-羟基vitamind 3或阿尔法拉啶醇(1α-OH-D 3)处理的部分改善的指标案例,并且我们观察到1,25-(OH)2 D血清浓度的显着增加,这表明了作用辅助物质25-羟化酶酶。最后,在接受钙二醇(25-OH-D 3)的患者中,我们记载了正常的24-羟化酶活性(CYP24A1)。这是第一次,并根据个性化医学的概念,我们证明了给予25-OH-D治疗的患者的显着改善(临床症状,生化数据和骨密度测定)。总之,目前的研究进一步扩展了CYP2R1突变谱。我们注意到VDDR1B可以很容易地误认为是古典维生素D缺乏症。还2017年美国骨骼和矿物学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号